Stockreport

Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer

Werewolf Therapeutics, Inc.  (HOWL) 
PDF WATERTOWN, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company [Read more]